IBRX
ImmunityBio, Inc. Common Stock
$7.79
-5.23%
-0.43
Notify me if price changes either direction
Buy IBRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
8.2B
Enterprise value
9.4B
Trailing PE
-20.53947323247
Forward PE
137
PEG Ratio
-0.065551510316394
Enterprise to EBITDA
-38.115
Enterprise to revenue
66.35
Price to book MRQ
-9.2216219440281
Price to sales TTM
61.068478
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
141.0M
EBITDA
-245412992
Diluted EPS TTM
-0.85
Total Cash (MRQ)
380.9M
Current ratio (MRQ)
6.666
Operating Cash Flow (TTM)
-294390016
IBRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
